Association between C-reactive protein and QTc interval in middle-aged men and women

European Journal of Epidemiology

Volumn 21, Issue 9, 2006, Pages 653-659

  Kim, Eunhee ^a   Joo, SoonJae ^b   Kim, Jinyoung ^b   Ahn, JeongCheon ^c   Kim, JeHyeong ^c   Kimm, Kuchan ^d   Shin, Chol ^b,c  

^a National Institute of Toxicological Research   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Korea National Institute of Health   (South Korea)

Author keywords

C reactive protein; Epidemiology; QT interval

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HEART RATE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; KOREA; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL EXAMINATION; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; QT INTERVAL; QUESTIONNAIRE; SEX RATIO; STATISTICAL SIGNIFICANCE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED;

EID: 33750928381     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9034-9     Document Type: Article

References (50)

1. Lepeschkin E, Surawicz B. Measurement of the QT interval of the electrocardiogram. Circulation 1952; 6: 378-388.
2. Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995; 122: 701-714.
3. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. Am J Cardiol 1993; 72: 23B-25B.
4. Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978; 57: 1074-1077.
5. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: The ARIC study. J Am Coll Cardiol 2004; 43: 565-571.
6. Robbins J, Nelson JC, Rautaharju PM, Gottdiener JS. The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med 2003; 115: 689-694.
7. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991; 84: 1516-1523.
8. Busjahn A, Knoblauch H, Faulhaber HD, et al. QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation 1999; 99: 3161-3164.
9. Woosley RL, Sale M. QT interval: A measure of drug action. Am J Cardiol 1993; 72: 36B-43B.
10. Ahnve S, Vallin H. Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 1982; 65: 435-439.
11. Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM. Autonomic nervous system influences on QT interval in normal subjects. J Am Coll Cardiol 2002; 39: 1820-1826.
12. Nakagawa M, Ooie T, Ou B, et al. Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 2005; 16: 278-284.
13. Bellavere F, Ferri M, Guarini L, et al. Prolonged QT period in diabetic autonomic neuropathy: A possible role in sudden cardiac death?. Br Heart J 1988; 59: 379-383.
14. Glickstein JS, Schwartzman D, Friedman D, Rutkowski M, Axelrod FB. Abnormalities of the corrected QT interval in familial dysautonomia: An indicator of autonomic dysfunction. J Pediatr 1993; 122: 925-928.
15. Diedrich A, Jordan J, Shannon JR, Robertson D, Biaggioni I. Modulation of QT interval during autonomic nervous system blockade in humans. Circulation 2002; 106: 2238-2243.
16. Du Clos TW. Function of C-reactive protein. Ann Med 2000; 32: 274-278.
17. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
18. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-1397.
19. Koenig W, Sund M, Frohlich M, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.
20. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-1128.
21. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
22. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462.
23. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-859.
24. Janszky I, Ericson M, Lekander M, et al. Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 2004; 256: 421-428.
25. Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: A study in patients with mild-to-moderate heart failure. Chest 2003; 123: 716-724.
26. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. C-reactive protein in young, apparently healthy men: Associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 2003; 52: 1113-1116.
27. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25: 363-370.
28. Shin C, Abbott RD, Lee H, Kim J, Kimm K. Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea: The Korean Health and Genome Study. J Hum Hypertens 2004; 18: 717-723.
29. Shin C, Lee S, Abbott RD, et al. Respiratory symptoms and undiagnosed airflow obstruction in middleaged adults: The Korean Health and Genome Study. Chest 2004; 126: 1234-1240.
30. Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 2001; 286: 64-70.
31. Kluft C, Leuven JA, Helmerhorst FM, Krans HM. Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vascul Pharmacol 2002; 39: 149-154.
32. Laiho K, Belt E, Maenpaa H, Kautiainen H, Kauppi M. Effect of daily corticosteroid treatment on CRP response to hip or knee replacement in patients with RA. Ann Rheum Dis 2001; 60: 989.
33. Bazett H. An analysis of time relations of the electrocardiograms. Heart 1920; 7: 353-367.
34. WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
35. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
36. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
37. Macfarlane PW. Minnesota coding and the prevalence of ECG abnormalities. Heart 2000; 84: 582-584.
38. Lane PW, Nelder JA. Analysis of covariance and standardization as instances of prediction. Biometrics 1982; 38: 613-621.
39. Roden DM, Spooner PM. Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis. J Cardiovasc Electrophysiol 1999; 10: 1664-1683.
40. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350: 1013-1022.
41. Peters RW, Byington RP, Barker A, Yusuf S. Prognostic value of prolonged ventricular repolarization following myocardial infarction: The BHAT experience. The BHAT Study Group. J Clin Epidemiol 1990; 43: 167-172.
42. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 2001; 8: 227-233.
43. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, Kromhout D. QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes 1996; 45: 376-380.
44. Gastaldelli A, Emdin M, Conforti F, Camastra S, Ferrannini E. Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol 2000; 279: R2022-R2025.
45. Carella MJ, Mantz SL, Rovner DR, et al. Obesity, adiposity, and lengthening of the QT interval: Improvement after weight loss. Int J Obes Relat Metab Disord 1996; 20: 938-942.
46. Madden K. Catecholamines, sympathetic nerves and immunity. In: Ader R, Felten D and Cohen N (eds.) Psychoneuroimmunology. 3rd edition. New York: Academic Press, 2004; 197-216.
47. Aronson D, Mittleman MA, Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001; 12: 294-300.
48. Jensen-Urstad M, Jensen-Urstad K, Ericson M, Johansson J. Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J Intern Med 1998; 243: 33-40.
49. Goldman MJ. Principles of Clinical Electrocardiography, 8th edn. In: Los Altos (ed), Lange Medical Publications, California 1973: 24-28.
50. Lepeschkin E. Mordern Electrocardiography. Vol. 1. Williams and Wilkins, Baltimore, MD, 1951.